Article
Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis.
Antimicrobial agents and chemotherapy - 1 Jul 2017
Sloan Derek J, McCallum Andrew D, Schipani Alessandro, Egan Deirdre, Mwandumba Henry C, Ward Steve A, Waterhouse David, Banda Gertrude, Allain Theresa J, Owen Andrew, Khoo Saye H, Davies Geraint R
Abstract excerpt
Variable exposure to antituberculosis (TB) drugs, partially driven by genetic factors, may be associated with poor clinical outcomes. Previous studies have suggested an influence of the SLCO1B1 locus on the plasma area under the concentration-time curve (AUC) of rifampin. We evaluated the contribution of single nucleotide polymorphisms (SNPs) in SLCO1B1 and other candidate genes (AADAC and CES-1) to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
